| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 04/10/2014 | WO2014055548A1 Anti-fibrotic pyridinones |
| 04/09/2014 | EP2714825A1 Polymer-bonded quaterrylene and/or terrylene dyes and compositions containing same |
| 04/09/2014 | EP2714659A1 Compounds with oxime ester and/or acyl groups |
| 04/09/2014 | CN103709102A Spiro ring-containing pleuromutilin antibiotics |
| 04/09/2014 | CN102898372B Preparation method of dextromethorphan |
| 04/09/2014 | CN102372673B Blonanserin crystallization and preparation method thereof |
| 04/09/2014 | CN101528704B Serine-threonine protein kinase and PARP modulators |
| 04/08/2014 | US8691837 Substituted imidazo ring systems and methods |
| 04/08/2014 | CA2572047C Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
| 04/03/2014 | WO2014048165A1 Compound as potassium channel modulator |
| 04/03/2014 | US20140094456 Anti-fibrotic pyridinones |
| 04/02/2014 | CN103702980A Cyclic amine derivatives as EP4 receptor antagonists |
| 04/02/2014 | CN103694163A Compounds capable of being adopted as potassium channel modulators |
| 04/02/2014 | CN101848970B Anthrapyridone compound, salt thereof, magenta ink composition and colored body |
| 04/01/2014 | US8686149 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 04/01/2014 | US8686146 Azaindenoisoquinoline topoisomerase I inhibitors |
| 04/01/2014 | CA2556086C Novel guanidinyl-substituted hydroxy-6-phenylphenenthridines as effective phosphodiesterase (pde) 4 inhibitors |
| 03/26/2014 | CN103687849A (--)- huperzine a processes and related compositions and methods of treatment |
| 03/26/2014 | CN103664782A Isocorydine derivative as well as preparation method and application thereof |
| 03/26/2014 | CN103655559A Application of incarvillateine compounds in preparation of anti-breast cancer drugs |
| 03/25/2014 | US8680268 Sulfonic acid derivative compound and novel naphthalic acid derivative compound |
| 03/25/2014 | US8680079 Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibitors |
| 03/25/2014 | CA2547020C 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier |
| 03/25/2014 | CA2466449C P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 03/20/2014 | WO2014041125A1 Specific inhibitors of protein p21 as therapeutic agents |
| 03/20/2014 | WO2014013507A4 A process for the preparation of tunable fluorescent polymer composition |
| 03/20/2014 | US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators |
| 03/20/2014 | US20140080220 Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions |
| 03/19/2014 | CN103641781A Application of naphthalimide type compounds and salts thereof as plant growth regulators |
| 03/18/2014 | US8674105 Crystalline hydrochloride salts of c-Met kinase inhibitors |
| 03/18/2014 | US8674104 Halogen-containing perylenetetracarboxylic acid derivatives and the use thereof |
| 03/18/2014 | US8673904 Epoxide inhibitors of cysteine proteases |
| 03/18/2014 | CA1341637C Chemiluminescent acridinium salts |
| 03/13/2014 | US20140073662 Spirocyclic nitriles as protease inhibitors |
| 03/13/2014 | US20140073059 Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions |
| 03/12/2014 | CN102827077B Preparation method for phenanthridine derivative |
| 03/12/2014 | CN102351870B Method for preparing benzacridine derivative and application of benzacridine derivative as anti-cancer medicine |
| 03/06/2014 | WO2014036502A2 Tetracycline compounds |
| 03/05/2014 | EP2703388A1 Compound with acridan ring structure, and organic electroluminescent element |
| 03/05/2014 | EP2701707A1 Method of treating dyskinesia |
| 03/05/2014 | CN103619821A Compound with acridan ring structure, and organic electroluminescent element |
| 03/05/2014 | CN103614134A Organic electroluminescent material and preparation method thereof |
| 03/05/2014 | CN103614133A Organic electroluminescent material and preparation method thereof |
| 03/05/2014 | CN102432535B Method for extracting and separating huperzine A and huperzine B from huperzia serrata |
| 03/04/2014 | US8664396 Photoluminescent metal complexes for protein staining |
| 03/04/2014 | US8664395 Purification 4-aza-androst-1-ene-17-oic acid from 4-aza-androstan-17-oic acid |
| 03/04/2014 | US8664238 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof |
| 02/27/2014 | WO2014031750A1 Acenaphthylene imide-derived semiconductors |
| 02/27/2014 | US20140057936 LPA2 Receptor-Specific Benzoic Acid Derivatives |
| 02/26/2014 | CN103601677A Preparation method of 2-alkylsulfenylquinoline derivative |
| 02/26/2014 | CN102775348B Naphthalimide derivative and application thereof |
| 02/19/2014 | CN103589421A Organic electroluminescent material and preparation method thereof |
| 02/19/2014 | CN103589420A Green organic electroluminescent material and preparation method thereof |
| 02/18/2014 | CA2716706C Compounds and compositions as tlr activity modulators |
| 02/13/2014 | WO2014024074A1 Boron containing perylene monoimides, process for their production, their use as building blocks for production of perylene monoimide derivatives, monoimide derivatives and their use in dye-sensitized solar cells |
| 02/13/2014 | US20140045880 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 02/13/2014 | US20140045875 Fused and Spirocycle Compounds and the Use Thereof |
| 02/13/2014 | US20140045746 Antidiabetic tricyclic compounds |
| 02/12/2014 | CN103570621A Preparation method of (-)-huperzine A |
| 02/12/2014 | CN103570620A 1,12-iminobenzo[c]phenanthrene compound, intermediate, preparation method and application of compound |
| 02/11/2014 | US8648070 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments |
| 02/06/2014 | WO2014022528A1 Antidiabetic tricyclic compounds |
| 02/06/2014 | WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound |
| 02/06/2014 | WO2014019186A1 Antidiabetic tricyclic compounds |
| 02/05/2014 | CN103554023A Synthesis method of acridine derivative and synthesized polycyclic acridine derivative |
| 02/05/2014 | CN103554011A Anthracene containing derivative as well as preparation method and application thereof |
| 02/04/2014 | US8642764 Julolidine conjugates and methods for their preparation and use |
| 02/04/2014 | US8642615 Methods of using 8-carboxamido-2,6-methano-3-benzazocines |
| 02/04/2014 | US8642610 Dual small molecule inhibitors of cancer and angiogenesis |
| 01/30/2014 | WO2014017042A1 Film-forming organic material, organic photoelectric conversion element obtained using same, imaging element, film-forming method, and method for manufacturing organic photoelectric conversion element |
| 01/30/2014 | WO2014016314A1 Fused quinonic compounds |
| 01/30/2014 | US20140031544 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 01/30/2014 | US20140031378 Insecticidal spironindane derivatives |
| 01/29/2014 | EP2690094A1 Fused quinonic compounds |
| 01/29/2014 | CN103547638A Polymer-bonded quaterrylene and/or terrylene dyes and compositions containing same |
| 01/29/2014 | CN103540313A Novel electroluminescent material and application thereof |
| 01/29/2014 | CN103539737A Aza-phenanthro-fluorene derivative and preparation method thereof as well as electrically-induced fluorescence luminescent device |
| 01/29/2014 | CN103539736A Method for synthesis of 2,3-cyclopentenopyridine from glycerin as raw material |
| 01/29/2014 | CN103539734A Preparation method of 3-allyl quinoline |
| 01/28/2014 | US8637658 Non-fluorescent quencher compounds and biomolecular assays |
| 01/28/2014 | US8637497 AZA spiro alkane derivatives as inhibitors of metalloproteases |
| 01/23/2014 | WO2014013507A1 A process for the preparation of tunable fluorescent polymer composition |
| 01/23/2014 | WO2014012964A1 New antifibrinolytic compounds |
| 01/22/2014 | CN103524414A Bridge ring derivative with aza-decadiene structure segment and synthesis method thereof |
| 01/22/2014 | CN102600105B Preparation method of sinomenine hydrochloride capsule |
| 01/15/2014 | CN103508953A Salts of nuciferine derivatives |
| 01/15/2014 | CN103508952A Salts of N-nornuciferine derivatives |
| 01/15/2014 | CN103508951A Salts of 2-hydroxy-1-methoxyaporphine derivative |
| 01/15/2014 | CN103508835A Indene benzophenanthrene derivative and organic light-emitting device using same |
| 01/14/2014 | US8628975 Methods and kits using extended rhodamine dyes |
| 01/14/2014 | US8628863 Indenopyrene compound and organic light-emitting device using the compound |
| 01/09/2014 | US20140013465 Papaver bracteatum with modified alkaloid content |
| 01/08/2014 | EP2682433A1 Carbonylpropylsulfonyl anthracene pyridone sulfonic acid compound and preparation method and use thereof |
| 01/08/2014 | EP2681199A1 (--)- huperzine a processes and related compositions and methods of treatment |
| 01/08/2014 | CN103497155A (+)-4-(2,3-dihydroxypropyl)-formamide-6-azabenzanthrone, and synthetic method and application thereof |
| 01/08/2014 | CN103497154A Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells |
| 01/07/2014 | US8624032 Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions |
| 01/07/2014 | US8623889 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof |
| 01/07/2014 | CA2635903C Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity |
| 01/01/2014 | CN103483256A (-)-4-(2,3-dihydroxypropxyl)-methanamide-6-azabenzanthrone as well as synthesis method and application thereof |